Log In
Print this Print this

cobas 4800 BRAF V600 Mutation Test

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionPCR-based nucleic acid test that identifies the BRAF V600E mutation in tumors
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsFirst line primary screening test for cervical cancer in women ages => 25 years; Identify BRAF V600E mutation in patients with metestatic melanoma
Regulatory Designation Japan - Standard Review (Identify BRAF V600E mutation in patients with metestatic melanoma)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today